Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2016-02-03 Interim / Quarterly Rep…
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filing by QIAGEN N.V. for the quarterly period ended December 31, 2015. It includes detailed unaudited financial results for the quarter and full year 2015, with adjusted net sales, operating income, net income, and earnings per share figures. The document references non-GAAP financial measures and reconciliations, discusses business performance, acquisitions, and outlook. The presence of detailed financial data and analysis for a quarterly period, along with the SEC Form 6-K designation (used by foreign private issuers to report quarterly or other periodic information), indicates this is an Interim / Quarterly Report. It is not an initial earnings release (ER) since it contains comprehensive financial data and management commentary. It is not an Annual Report (10-K) or Audit Report (AR). The document is substantive and not merely an announcement or certification, so it is not RPA or RNS. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2016-02-03 English
QIAGEN reports results for fourth quarter and full-year 2015
Earnings Release Classification · 98% confidence The document is titled "QIAGEN reports results for fourth quarter and full-year 2015" and contains detailed financial metrics, including adjusted net sales, operating income, EPS, cash flow figures, and segment performance breakdowns for both Q4 2015 and the full year 2015. It explicitly discusses financial results and outlook for the upcoming year (2016). This content structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, often including key highlights and summary tables before a more comprehensive report (like a 10-K or IR) is filed. Since it focuses on the immediate release of period results, 'ER' is the most appropriate classification over 'IR' (Interim Report) or '10-K' (Annual Report). The document length is substantial (over 62k characters), indicating it is the primary release document, not just a brief announcement of publication (RPA). Q4 2015
2016-02-03 English
6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by QIAGEN N.V., which is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. It contains preliminary unaudited financial results for the full-year 2015 and fourth quarter 2015, as well as an outlook for 2016. The document includes press releases and an ad hoc announcement with detailed financial data, including adjusted net sales, earnings per share, and currency impact analysis. It also mentions upcoming full financial results and a conference call. The presence of detailed financial data and analysis for a period shorter than a full fiscal year (quarter and preliminary full-year results) and the nature of the filing (6-K) indicate this is an interim or quarterly report type document. It is not a full annual report (10-K or 20-F), nor is it merely an announcement of a report publication. The document is substantive and contains financial data and management commentary. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2016-01-11 English
QIAGEN announces preliminary results for full-year 2015 and provides 2016 outlook
Earnings Release Classification · 100% confidence The document is titled "QIAGEN announces preliminary results for full-year 2015 and provides 2016 outlook" and contains specific preliminary financial figures for the fourth quarter and full-year 2015, along with a financial outlook for 2016. It explicitly mentions that the results are unaudited and that full financial results will be reported on February 2nd. This structure—announcing preliminary figures ahead of the official filing—is characteristic of an Earnings Release (ER), which provides key highlights before the comprehensive report (like a 10-K or IR). It is not the full report itself, nor is it a transcript or a presentation. FY 2015
2016-01-11 English
Regulatory Filings 2015
Regulatory Filings
2015-11-05 English
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed with the SEC by QIAGEN N.V., which contains a 'U.S. GAAP Quarterly Report' for the period ended September 30, 2015. It includes comprehensive financial statements (Balance Sheets, Income Statements, etc.) and management analysis. Since it provides substantive financial data for a quarterly period, it is classified as an Interim/Quarterly Report (IR). 9M 2015
2015-10-30 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.